Increasing the probability of technical success in drug development using AI and patient heterogeneity
Predictive Oncology
AUGUST 8, 2024
A recent white paper released by Predictive Oncology’s highlights the challenge of late-stage clinical trial failures and the company’s ability to better navigate those obstacles and increase the probability of technical success which is a key metric in target selection, clinical trial design and pipeline replenishment.
52 
Let's personalize your content